APP and Alzheimer disease: This study demonstrated, both in vivo and in vitro, that ATF6 overexpression reduced Aβ production by inhibiting amyloid precursor protein (APP) expression, downregulated the promoter activity and expression of BACE1, and protected the retention of spatial memory in AD mice.